RxDoctor Payments Data

Santosh Oommen, MD

Clinical Cardiac Electrophysiology · Monterey, CANPI 1427104256

Payments from drug & device makers

$7,489in general payments, 2019–2025

Across 98 payments — averaging $76.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$4K
  • Biosense Webster, Inc.$1K
  • Boston Scientific$731
  • Medical Device Business Services, Inc.$709
  • Medtronic$470
  • Elutia, Inc.$160
  • plus $503 from 5 others

What the payments were for

  • Travel & lodging$2,88539%
  • Food & beverage$4,60461%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,489 in reported general payments places this provider in the 15th percentile of 290 clinical cardiac electrophysiology providers in California.

See all clinical cardiac electrophysiology providers in California

Medicare billing

Part B allowed, 2024
$372,937
Medicare patients
1,037
Services billed
3,752

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban324$457,426
XareltoRivaroxaban135$186,860
EntrestoSacubitril/Valsartan31$37,369
FarxigaDapagliflozin Propanediol20$24,071
Dofetilide45$23,779
Flecainide Acetate105$6,343
Metoprolol Succinate340$6,139
Propafenone Hcl31$2,725
Diltiazem 24hr Er (Cd)Diltiazem Hcl57$2,386
Mexiletine Hcl14$1,595
Lisinopril111$1,588
Atorvastatin Calcium93$1,421
Carvedilol109$1,272
Bumetanide20$1,159
Spironolactone92$976

Paid to pharmacies, not to this prescriber.

Other clinical cardiac electrophysiology in Monterey

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →